Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce J Brew

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Plos Pathogens|August 8, 2024
HIV transcription persists in the brain of virally suppressed people with HIVJanna Jamal Eddine, Thomas A Angelovich, Jingling Zhou, et al.
International Journal of Tryptophan Research : IJTR|May 17, 2024
A Review of the Evidence for Tryptophan and the Kynurenine Pathway as a Regulator of Stem Cell Niches in Health and DiseaseBenjamin Sebastian Summers, Sarah Thomas Broome, Tsz Wai Rosita Pang, et al.
Plos Pathogens|March 29, 2023
Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaquesSarah J Byrnes, Kathleen Busman-Sahay, Thomas A Angelovich, et al.
Annals of Neurology|July 26, 2023
Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIVThomas A Angelovich, Catherine R Cochrane, Jingling Zhou, et al.
Annals of Neurology|July 22, 2022
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ARTCatherine R Cochrane, Thomas A Angelovich, Sarah J Byrnes, et al.
AIDS (London, England)|February 10, 2018
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell countsEdwina J Wright, Birgit Grund, Kevin R Robertson, et al.
Nature Communications|April 17, 2024
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infectionChansavath Phetsouphanh, Brendan Jacka, Sara Ballouz, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Plos Pathogens|August 8, 2024
HIV transcription persists in the brain of virally suppressed people with HIVJanna Jamal Eddine, Thomas A Angelovich, Jingling Zhou, et al.
International Journal of Tryptophan Research : IJTR|May 17, 2024
A Review of the Evidence for Tryptophan and the Kynurenine Pathway as a Regulator of Stem Cell Niches in Health and DiseaseBenjamin Sebastian Summers, Sarah Thomas Broome, Tsz Wai Rosita Pang, et al.
Plos Pathogens|March 29, 2023
Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaquesSarah J Byrnes, Kathleen Busman-Sahay, Thomas A Angelovich, et al.
Annals of Neurology|July 26, 2023
Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIVThomas A Angelovich, Catherine R Cochrane, Jingling Zhou, et al.
Annals of Neurology|July 22, 2022
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ARTCatherine R Cochrane, Thomas A Angelovich, Sarah J Byrnes, et al.
AIDS (London, England)|February 10, 2018
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell countsEdwina J Wright, Birgit Grund, Kevin R Robertson, et al.
Nature Communications|April 17, 2024
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infectionChansavath Phetsouphanh, Brendan Jacka, Sara Ballouz, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Pageof 18